These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7646071)
1. "Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Wade ML; Voelkel NF; Fitzpatrick FA Arch Biochem Biophys; 1995 Aug; 321(2):453-8. PubMed ID: 7646071 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of ibuprofen, indomethacin, and meclofenamate on prostaglandin endoperoxide H2 metabolism. Mayeux PR; Kadowitz PJ; McNamara DB Mol Cell Biochem; 1989 May; 87(1):41-6. PubMed ID: 2505061 [TBL] [Abstract][Full Text] [Related]
3. "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets. Jones DA; Fitzpatrick FA J Biol Chem; 1990 Nov; 265(33):20166-71. PubMed ID: 2243085 [TBL] [Abstract][Full Text] [Related]
4. Bovine prostacyclin synthase: purification and isolation of partial cDNA. Pereira B; Wu KK; Wang LH Biochem Biophys Res Commun; 1993 Dec; 197(3):1041-8. PubMed ID: 8280118 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase. Wade ML; Fitzpatrick FA Arch Biochem Biophys; 1997 Nov; 347(2):174-80. PubMed ID: 9367522 [TBL] [Abstract][Full Text] [Related]
6. [Significance of the PGI2 producing enzyme system in the pathogenesis of pregnancy-induced hypertension]. Seki H; Mitsuhashi N; Mizuno M; Satoh K Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1189-94. PubMed ID: 2120373 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism. Reed GA; Griffin IO; Eling TE Mol Pharmacol; 1985 Jan; 27(1):109-14. PubMed ID: 3917545 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Marnett LJ; Siedlik PH; Ochs RC; Pagels WR; Das M; Honn KV; Warnock RH; Tainer BE; Eling TE Mol Pharmacol; 1984 Sep; 26(2):328-35. PubMed ID: 6434940 [TBL] [Abstract][Full Text] [Related]
9. A concept for the mechanism of prostacyclin and thromboxane A2 biosynthesis. Ullrich V; Hecker M Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():95-101. PubMed ID: 2144703 [No Abstract] [Full Text] [Related]
10. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736 [TBL] [Abstract][Full Text] [Related]
11. Irreversible inactivation of monoterpene cyclases by a mechanism-based inhibitor. Croteau R; Alonso WR; Koepp AE; Shim JH; Cane DE Arch Biochem Biophys; 1993 Dec; 307(2):397-404. PubMed ID: 8274028 [TBL] [Abstract][Full Text] [Related]
12. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]